Mamas fibrocísticas

Marchant DJ. Benign breast disease. Obstet Gynecol Clin North Am. 2002 Mar;29(1):1-20. Resumo

Santen RJ, Mansel R. Benign breast disorders. N Engl J Med. 2005 Jul 21;353(3):275-85. Resumo

Love SM, Gelman RS, Silen W. Sounding board. Fibrocystic "disease" of the breast--a nondisease? N Eng J Med. 1982 Oct 14;307(16):1010-4. Resumo

Dupont WD, Page DL. Risk factors for breast cancer in women with proliferative breast disease. N Engl J Med. 1985 Jan 17;312(3):146-51. Resumo

Fisher B, Constantino JP, Wickerham DL, et al. Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study. J Natl Cancer Inst. 1998 Sep 16;90(18):1371-88.Texto completo  Resumo

1. Marchant DJ. Benign breast disease. Obstet Gynecol Clin North Am. 2002 Mar;29(1):1-20. Resumo

2. Santen RJ, Mansel R. Benign breast disorders. N Engl J Med. 2005 Jul 21;353(3):275-85. Resumo

3. Goehring C, Morabia A. Epidemiology of benign breast disease, with special attention to histologic types. Epidemiol Rev. 1997;19(2):310-27.Texto completo  Resumo

4. Gopalani SV, Janitz AE, Martinez SA, et al. Trends in cancer incidence among American Indians and Alaska natives and non-Hispanic whites in the United States, 1999-2015. Epidemiology. 2020 Mar;31(2):205-13. Resumo

5. Sarnelli R, Squartini F. Fibrocystic condition and "at risk" lesions in asymptomatic breasts: a morphologic study of postmenopausal women. Clin Exp Obstet Gynecol. 1991;18(4):271-9. Resumo

6. Rohan TE, Miller AB. Hormone replacement therapy and risk of benign proliferative epithelial disorders of the breast. Eur J Cancer Prev. 1999 Apr;8(2):123-30. Resumo

7. Wang DY, Fentiman IS. Epidemiology and endocrinology of benign breast disease. Breast Cancer Res Treat. 1985;6(1):5-36. Resumo

8. Love SM, Gelman RS, Silen W. Sounding board. Fibrocystic "disease" of the breast--a nondisease? N Eng J Med. 1982 Oct 14;307(16):1010-4. Resumo

9. Roger P, Sahla ME, Makela S, et al. Decreased expression of estrogen receptor beta protein in proliferative preinvasive mammary tumors. Cancer Res. 2001 Mar 15;61(6):2537-41.Texto completo  Resumo

10. Duffy SW, Roberts MM, Elton RA. Risk factors relevant to cystic breast disease: a case-control study. J Epidemiol Community Health. 1983 Dec;37(4):271-3.Texto completo  Resumo

11. Cole P, Elwood JM, Kaplan SD. Incidence rates and risk factors of benign breast neoplasms. Am J Epidemiol. 1978 Aug;108(2):112-20. Resumo

12. Rohan TE, Negassa A, Chlebowski RT, et al. Conjugated equine estrogen and risk of benign proliferative breast disease: a randomized controlled trial. J Natl Cancer Inst. 2008 Apr 16;100(8):563-71.Texto completo  Resumo

13. Cady B, Steele GD Jr, Morrow M, et al. Evaluation of common breast problems: guidance for primary care providers. CA Cancer J Clin. 1998 Jan-Feb;48(1):49-63. Resumo

14. Seltzer MH. Breast complaints, biopsies, and cancer correlated with age in 10,000 consecutive new surgical referrals. Breast J. 2004 Mar-Apr;10(2):111-7. Resumo

15. Davies EL, Gateley CA, Miers M, et al. The long-term course of mastalgia. J R Soc Med. 1998 Sep;91(9):462-4.Texto completo  Resumo

16. Mohallem Fonseca M, Lamb LR, Verma R, et al. Breast pain and cancer: should we continue to work-up isolated breast pain? Breast Cancer Res Treat. 2019 Oct;177(3):619-27. Resumo

17. Kushwaha AC, Shin K, Kalambo M, et al. Overutilization of health care resources for breast pain. AJR Am J Roentgenol. 2018 Jul;211(1):217-23.Texto completo  Resumo

18. Tang SS, Twelves DJ, Isacke CM, Gui GP. Mammary ductoscopy in the current management of breast disease. Surg Endosc. 2011 Jun;25(6):1712-22. Resumo

19. Newman HF, Klein M, Northrup JD, et al. Nipple discharge. Frequency and pathogenesis in an ambulatory population. N Y State J Med. 1983 Jun;83(7):928-33. Resumo

20. Dupont WD, Page DL. Risk factors for breast cancer in women with proliferative breast disease. N Engl J Med. 1985 Jan 17;312(3):146-51. Resumo

21. Gemignani ML. Breast cancer screening: why, when, and how many? Clin Obstet Gynecol. 2002 Mar;29(1):1-20. Resumo

22. Horrobin DF, Manku MS. Premenstrual syndrome and premenstrual breast pain (cyclical mastalgia): disorders of essential fatty acid (EFA) metabolism. Prostaglandins Leukot Essent Fatty Acids. 1989 Sep;37(4):255-61. Resumo

23. Pruthi S, Wahner-Roedler DL, Torkelson CJ, et al. Vitamin E and evening primrose oil for management of cyclical mastalgia: a randomized pilot study. Altern Med Rev. 2010 Apr;15(1):59-67. Resumo

24. Fentiman IS, Caleffi M, Hamed H, et al. Dosage and duration of tamoxifen treatment for mastalgia: a controlled trial. Br J Surg. 1988 Sep;75(9):845-6. Resumo

25. Parlati E, Polinari U, Salvi G, et al. Bromocriptine for treatment of benign breast disease. A double-blind clinical trial versus placebo. Acta Obstet Gynecol Scand. 1987;66(6):483-8. Resumo

26. Mansel RE, Wisbey JR, Hughes LE. Controlled trial of the antigonadotropin danazol in painful nodular benign breast disease. Lancet. 1982 Apr 24;1(8278):928-30. Resumo

27. Smith RL, Pruthi S, Fitzpatrick LA. Evaluation and management of breast pain. Mayo Clin Proc. 2004 Mar;79(3):353-72. Resumo

28. Rosolowich V, Saettler E, Szuck B, et al. Mastalgia. J Obstet Gynaecol Can. 2006 Jan;28(1):49-57.Texto completo  Resumo

29. Basch E, Bent S, Collins J, et al. Flax and flaxseed oil (Linum usitatissimum): A review by the natural standard research collaboration. J Soc Integr Oncol. 2007 Summer;5(3):92-105. Resumo

30. Murshid KRA. Review of mastalgia in patients with fibrocystic breast changes and the non-surgical treatment options. J Taibah Uni Med Sci. 2011;6(1):1-18.

31. Vargas HI, Vargas MP, Gonzalez KD, et al. Outcomes of sonography-based management of breast cysts. Am J Surg. 2004 Oct;188(4):443-7. Resumo

32. The American Society of Breast Surgeons. Benign breast disease. Five things physicians and patients should question. Jan 2018 [internet publication].Texto completo

33. Hartmann LC, Sellers TA, Frost MH, et al. Benign breast disease and the risk of breast cancer. N Engl J Med. 2005 Jul 21;353(3):229-37.Texto completo  Resumo

34. Fisher B, Constantino JP, Wickerham DL, et al. Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study. J Natl Cancer Inst. 1998 Sep 16;90(18):1371-88.Texto completo  Resumo

35. Vargas HI, Romero L, Chlebowski RT. Management of bloody nipple discharge. Curr Treat Options Oncol. 2002 Apr;3(2):157-61. Resumo

36. Srivastava A, Mansel RE, Arvind N, et al. Evidence-based management of Mastalgia: a meta-analysis of randomised trials. Breast. 2007 Oct;16(5):503-12. Resumo

37. Vargas HI, Vargas MP, Eldrageely K, et al. Outcomes of clinical and surgical assessment of women with pathological nipple discharge. Am Surg. 2006 Feb;72(2):124-8. Resumo

38. Kessler JH. The effect of supraphysiologic levels of iodine on patients with cyclic mastalgia. Breast J. 2004 Jul-Aug;10(4):328-36. Resumo

39. Ghent WR, Eskin BA, Low DA, et al. Iodine replacement in fibrocystic disease of the breast. Can J Surg. 1993 Oct;36(5):453-60. Resumo

40. Bevers TB. Breast awareness: a shift in the paradigm of breast self-examination. J Natl Compr Canc Netw. 2009 Nov;7(10):1042-3. Resumo

41. Thornton H, Pillarisetti RR. 'Breast awareness' and 'breast self-examination' are not the same. What do these terms mean? Why are they confused? What can we do? Eur J Cancer. 2008 Oct;44(15):2118-21. Resumo